Cell & Gene Therapy INSIGHTS

Business Insights January 2021

February 2021

  • Business Insight: cell & gene therapy

    J Mulryne,
    Jackie Mulryne
    Partner, Arnold & Porter
    Jackie Mulryne is a Partner at Arnold & Porter, focusing on regulatory and contentious matters for life sciences companies. She has advised a range of clients on the development and launch of innovative products, and assisted with navigating the regulatory landscape for novel cell and gene therapy products.
    B San Martin,
    Dr Beatriz San Martin
    Partner, Arnold & Porter
    Beatriz San Martin is an intellectual property specialist focusing her practice on the life sciences sector and emerging/disruptive technologies. She has significant experience handling cases before the UK Courts and the Court of Justice of the European Union, including high-profile European litigation. Beatriz was formerly a scientist with a Wellcome Trust PhD and a postdoctoral from the University of Cambridge specializing in genetics, cellular, and molecular biology. She is a member of the UK BioIndustry Association Cell and Gene Therapy Advisory Committee and Engineering Biology Advisory Committee.
    J Schmidt et al.
    John Schmidt
    Partner, Arnold & Porter
    1 February 2021
    Expert Insight

Other reports from Cell and Gene Therapy insights